Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Fenwal, Inc.. The primary component is Anhydrous Citric Acid; Dextrose Monohydrate; Sodium Phosphate, Monobasic, Monohydrate; Trisodium Citrate Dihydrate.
| Product ID | 0942-9201_1ee1e424-2028-4b58-b554-883d2e359c28 |
| NDC | 0942-9201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic |
| Generic Name | Anticoagulant Citrate Phosphate Dextrose (cpd) Solution |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2007-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | BN170401 |
| Labeler Name | Fenwal, Inc. |
| Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Active Ingredient Strength | 105 mg/35mL; mg/35mL; mg/35mL; mg/35mL |
| Pharm Classes | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |